Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells
The regulator of G protein signaling 10 (RGS10) protein is a GTPase activating protein that accelerates the hydrolysis of GTP and therefore canonically inactivates G proteins, ultimately terminating signaling. Rheb is a small GTPase protein that shuttles between its GDP- and GTP-bound forms to activate mTOR. Since RGS10 suppression augments ovarian cancer cell viability, we sought to elucidate the molecular mechanism. Following RGS10 suppression in serum-free conditions, phosphorylation of mTOR, the eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1), p70S6K and S6 Ribosomal Protein appear. Furthermore, suppressing RGS10 increases activated Rheb, suggesting RGS10 antagonizes mTOR signaling via the small G-protein. The effects of RGS10 suppression are enhanced after stimulating cells with the growth factor, lysophosphatidic acid, and reduced with mTOR inhibitors, temsirolimus and INK-128. Suppression of RGS10 leads to an increase in cell proliferation, even in the presence of etoposide. In summary, the RGS10 suppression increases Rheb-GTP and mTOR signaling in ovarian cancer cells. Our results suggest that RGS10 could serve in a novel, and previously unknown, role by accelerating the hydrolysis of GTP from Rheb in ovarian cancer cells..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:369 |
---|---|
Enthalten in: |
Cancer letters - 369(2015), 1, Seite 175 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Altman, Molly K [VerfasserIn] |
---|
Links: |
---|
doi: |
10.1016/j.canlet.2015.08.012 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC196365420X |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC196365420X | ||
003 | DE-627 | ||
005 | 20230516073238.0 | ||
007 | tu | ||
008 | 160206s2015 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1016/j.canlet.2015.08.012 |2 doi | |
028 | 5 | 2 | |a PQ20160617 |
035 | |a (DE-627)OLC196365420X | ||
035 | |a (DE-599)GBVOLC196365420X | ||
035 | |a (PRQ)c1790-3b50fc49e91a35b4c548fd75a0596cab0f6320431c04e83de3011ee1df7f3d0e0 | ||
035 | |a (KEY)0019274020150000369000100175suppressionofthegtpaseactivatingproteinrgs10increa | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 570 |q DNB |
084 | |a BIODIV |2 fid | ||
100 | 1 | |a Altman, Molly K |e verfasserin |4 aut | |
245 | 1 | 0 | |a Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a The regulator of G protein signaling 10 (RGS10) protein is a GTPase activating protein that accelerates the hydrolysis of GTP and therefore canonically inactivates G proteins, ultimately terminating signaling. Rheb is a small GTPase protein that shuttles between its GDP- and GTP-bound forms to activate mTOR. Since RGS10 suppression augments ovarian cancer cell viability, we sought to elucidate the molecular mechanism. Following RGS10 suppression in serum-free conditions, phosphorylation of mTOR, the eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1), p70S6K and S6 Ribosomal Protein appear. Furthermore, suppressing RGS10 increases activated Rheb, suggesting RGS10 antagonizes mTOR signaling via the small G-protein. The effects of RGS10 suppression are enhanced after stimulating cells with the growth factor, lysophosphatidic acid, and reduced with mTOR inhibitors, temsirolimus and INK-128. Suppression of RGS10 leads to an increase in cell proliferation, even in the presence of etoposide. In summary, the RGS10 suppression increases Rheb-GTP and mTOR signaling in ovarian cancer cells. Our results suggest that RGS10 could serve in a novel, and previously unknown, role by accelerating the hydrolysis of GTP from Rheb in ovarian cancer cells. | ||
540 | |a Nutzungsrecht: Copyright © 2015 Elsevier Ireland Ltd. All rights reserved. | ||
650 | 4 | |a Ovarian cancer | |
650 | 4 | |a mTOR | |
650 | 4 | |a American Recovery & Reinvestment Act 2009-US | |
650 | 4 | |a Studies | |
650 | 4 | |a Cell growth | |
650 | 4 | |a Kinases | |
650 | 4 | |a Regulator of G protein Signaling 10 protein (RGS10) | |
650 | 4 | |a Phosphorylation | |
650 | 4 | |a 4E-BP1 | |
650 | 4 | |a DNA methylation | |
650 | 4 | |a Proteins | |
650 | 4 | |a Rheb | |
650 | 4 | |a Lysophosphatidic acid | |
700 | 1 | |a Alshamrani, Ali A |4 oth | |
700 | 1 | |a Jia, Wei |4 oth | |
700 | 1 | |a Nguyen, Ha T |4 oth | |
700 | 1 | |a Fambrough, Jada M |4 oth | |
700 | 1 | |a Tran, Sterling K |4 oth | |
700 | 1 | |a Patel, Mihir B |4 oth | |
700 | 1 | |a Hoseinzadeh, Pooya |4 oth | |
700 | 1 | |a Beedle, Aaron M |4 oth | |
700 | 1 | |a Murph, Mandi M |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Cancer letters |d Amsterdam : Elsevier, 1975 |g 369(2015), 1, Seite 175 |w (DE-627)166458880 |w (DE-600)195674-7 |w (DE-576)01481272X |x 0304-3835 |7 nnns |
773 | 1 | 8 | |g volume:369 |g year:2015 |g number:1 |g pages:175 |
856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.canlet.2015.08.012 |3 Volltext |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26319900 |
856 | 4 | 2 | |u http://search.proquest.com/docview/1719447606 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-BIODIV | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4219 | ||
951 | |a AR | ||
952 | |d 369 |j 2015 |e 1 |h 175 |